Translational Session
Modern Scientific Breakthroughs: Are COVID-19 Vaccines Enough for Kidney Transplant Recipients?
November 04, 2022 | 02:00 PM - 04:00 PM
Location: WF3 Tangerine, Orange County Convention Center, West Building
Session Description
The clinical trials for COVID-19 vaccines were executed with unprecedented efficiency, with three safe and effective vaccines authorized within a year. This achievement is one of the major scientific milestones achieved in recent years. Some studies have found that vaccinated transplant recipients produce a weak immune response. This session discusses recent evidence about COVID-19 vaccines and the mechanisms associated with establishing immune responses, with a special focus on kidney transplant recipients.
Learning Objective(s)
- Discuss recent evidence about the effect of COVID-19 vaccines in establishing an immune response in kidney transplant recipients
- Describe the mechanisms associated with establishing immune response against COVID-19
- Evaluate the optimal COVID-19 vaccine regimen for kidney transplant recipients
- Analyze available data from clinical trials to optimize immunosuppression management for patients
Learning Pathway(s)
- Kidney Transplantation
Moderators
- Dianne B. McKay, MD
- Miklos Zsolt Molnar, MD, PhD, FASN
Presentations
- COVID-19: Tweaking Immune Responses
02:00 PM - 02:30 PM
Maricar Malinis, MD
- COVID-19: What We Know About Humoral and Cellular Responses?
02:30 PM - 03:00 PM
Paolo Cravedi, MD, PhD
- Immune Responses in Transplant Recipients Who Received a Third Dose of mRNA-1273
03:00 PM - 03:30 PM
Atul Humar, MD, MS, MSc
- Vaccine Effectiveness in Transplant Recipients
03:30 PM - 04:00 PM
Andrew H. Karaba, MD, PhD
